Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication
<p>Abstract</p> <p>Interferon alpha (IFN-α)-based therapy is the currently approved treatment for chronic hepatitis C viral infection. The sustained antiviral response rate is approximately 50% for genotype-1 infection. The major challenge to the HCV community is to improve antivir...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2005-09-01
|
| Series: | Virology Journal |
| Online Access: | http://www.virologyj.com/content/2/1/80 |